7th Oct 2022 09:37
Croda International PLC - Yorkshire, England-based chemicals maker - Says its recent "strong" organic growth from its drug delivery platforms - excluding its Covid-19 lipid systems - has continued. Sees its "exciting innovation" pipeline hitting commercialisation from 2025. The platform sits within its Health Care business, which forms part of the firm's Life Sciences unit. Read More